Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Mistler, L. A. Articles by Rosenberg, S. D. Search for Related Content PubMed Citation Articles by Mistler, L. A. Articles by Rosenberg, S. D. Primary Care Other Delivery of Care Other Somatic Therapy

Hepatitis C Treatment for People With Severe Mental Illness

Received May 7, 2004; revised June 16, July 28, 2004; accepted March 31, 2005. From Dartmouth Medical School, Hanover NH and New Hampshire Hospital, Concord, NH. Send correspondence and reprint requests to Lisa A. Mistler, M.D., at the New Hampshire Hospital Unit C, 36 Clinton St., Concord, NH 03301. e-mail: Lisa.A.Mistler{at}dartmouth.edu
© 2006 The Academy of Psychosomatic Medicine

Over 4 million people in the United States are chronically infected with hepatitis C virus (HCV), and, if untreated, over 20% of these will progress to more serious disease. Persons with severe mental illness (SMI) have markedly elevated rates of HCV infection, but treatment of persons with SMI and HCV has been controversial. Effective antiviral treatment is available, but side effects include depression and other neuropsychiatric symptoms. This article reviews the available data on neuropsychiatric side effects of interferon (IFN) treatment, discusses the limitations of the current research, and makes recommendations regarding HCV treatment in persons with SMI.

This article has been cited by other articles:

				M. Huckans, A. Mitchell, S. Ruimy, J. Loftis, and P. Hauser Antiviral Therapy Completion and Response Rates Among Hepatitis C Patients With and Without Schizophrenia Schizophr Bull, June 17, 2008; (2008) sbn065v1. [Abstract] [Full Text] [PDF]

				O. Freudenreich, R. T. Gandhi, J. P. Walsh, D. C. Henderson, and D. C. Goff Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort Psychosomatics, October 1, 2007; 48(5): 405 - 411. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us